KEIRSTEN MONTGOMERY: Open Payments
NPI 1023261492 · MOUNT VERNON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,258 in 102 payments from 28 companies in 2025. Trend: 2023 $3,203 · 2024 $3,840 · 2025 $2,258
Food & beverage: $2,258
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $422 |
| Corcept Therapeutics | 10 | $241 |
| Amgen Inc. | 14 | $199 |
| Insulet Corporation | 7 | $186 |
| Lilly USA, LLC | 12 | $149 |
| ABBVIE INC. | 6 | $127 |
| Neurocrine BioSciences, Inc. | 4 | $105 |
| Abbott Laboratories | 4 | $104 |
| BETA BIONICS, INC. | 3 | $101 |
| SANOFI-AVENTIS U.S. LLC | 4 | $88 |
Products named: Ozempic, Korlym, Omnipod, SYNTHROID, CRENESSITY, FREESTYLE LIBRE 3, iLet Bionic Pancreas, EVENITY.
Industry payments across WA — which companies pay providers there.
